Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
5.04
0.00 (0.00%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Upstream Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 79.4 | 101.58 | 325.89 | 25.83 | 17.05 |
Short-Term Investments | 181.91 | 239.93 | 144.56 | 83.98 | - |
Cash & Short-Term Investments | 261.31 | 341.51 | 470.45 | 109.81 | 17.05 |
Cash Growth | -33.61% | -27.41% | 328.42% | 544.01% | - |
Accounts Receivable | 0.77 | 0.67 | 0.61 | 0.1 | 0.41 |
Other Receivables | 1.38 | 1.65 | 0.57 | 0.14 | - |
Receivables | 2.15 | 2.32 | 1.18 | 0.24 | 0.41 |
Prepaid Expenses | 0.3 | 0.88 | 0.85 | 0.02 | 0.09 |
Other Current Assets | 15.85 | 7.09 | 6.68 | 6.93 | 0.75 |
Total Current Assets | 279.6 | 351.8 | 479.16 | 117 | 18.31 |
Property, Plant & Equipment | 1.38 | 1.78 | 2.37 | 0.2 | 0.16 |
Other Long-Term Assets | 0.19 | 0.19 | 0.19 | - | 0.01 |
Total Assets | 281.17 | 353.77 | 481.72 | 117.2 | 18.48 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 2.31 | 2.73 | 4.04 | 1.99 | 0.71 |
Accrued Expenses | 6.95 | 10.01 | 5.99 | 4.48 | 4.06 |
Current Portion of Leases | 0.73 | 0.72 | 0.7 | 0.05 | 0.09 |
Total Current Liabilities | 9.99 | 13.45 | 10.74 | 6.52 | 4.86 |
Long-Term Leases | 0.23 | 0.55 | 1.13 | - | 0.01 |
Other Long-Term Liabilities | - | - | - | 2.87 | 6.95 |
Total Liabilities | 10.21 | 14 | 11.87 | 9.39 | 11.81 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 0.05 | 0.05 | 0.05 | 0 | 0 |
Additional Paid-In Capital | 685.54 | 673.41 | 660.6 | 4.82 | 1.28 |
Retained Earnings | -414.52 | -334.22 | -190.78 | -127.97 | -107.44 |
Comprehensive Income & Other | -0.12 | 0.53 | -0.03 | 0.02 | - |
Total Common Equity | 270.96 | 339.77 | 469.85 | -123.13 | -106.16 |
Shareholders' Equity | 270.96 | 339.77 | 469.85 | 107.81 | 6.67 |
Total Liabilities & Equity | 281.17 | 353.77 | 481.72 | 117.2 | 18.48 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 0.95 | 1.27 | 1.83 | 0.05 | 0.09 |
Net Cash (Debt) | 260.35 | 340.24 | 468.62 | 109.77 | 16.96 |
Net Cash Growth | -33.59% | -27.40% | 326.93% | 547.31% | - |
Net Cash Per Share | 4.80 | 6.32 | 34.25 | 37.16 | 6.06 |
Filing Date Shares Outstanding | 54.77 | 54.42 | 53.64 | 2.85 | 2.8 |
Total Common Shares Outstanding | 54.77 | 54.24 | 53.6 | 2.85 | 2.8 |
Working Capital | 269.61 | 338.35 | 468.42 | 110.48 | 13.45 |
Book Value Per Share | 4.95 | 6.26 | 8.77 | -43.16 | -37.91 |
Tangible Book Value | 270.96 | 339.77 | 469.85 | -123.13 | -106.16 |
Tangible Book Value Per Share | 4.95 | 6.26 | 8.77 | -43.16 | -37.91 |
Machinery | 0.82 | 0.82 | 0.67 | 0.2 | 0.02 |
Construction In Progress | - | - | - | - | 0.04 |
Leasehold Improvements | 0.09 | 0.09 | 0.07 | 0.03 | 0.02 |